Drug prescription in pregnancy: analysis of a large statutory sickness fund population
- 7 October 2004
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 60 (9) , 659-666
- https://doi.org/10.1007/s00228-004-0817-1
Abstract
To examine the prescription of drugs in Germany prior to, during and after pregnancy. For the first time, prescription data of a large cohort of pregnant women, from a German statutory sickness fund, were available for scientific analysis. For each woman who gave birth between June 2000 and May 2001 reimbursed prescriptions for two periods (90 days each) before pregnancy, three during and two after delivery were considered. The drugs were classified according to the ATC code. Of the 41,293 women, 96.4% received at least one drug during pregnancy. A median of 7 drugs per women was prescribed. Excluding vitamins, minerals, iodide and iron, 85.2% received at least one drug and the median was 3. Magnesium, which was seldom prescribed outside of pregnancy, was by far the most frequently prescribed substance (20% of all prescriptions, 61% of the women). Iron (54% of the women) and iodide (31%) were also prescribed often. The prescription rates of gynaecological antiinfectives (maximum in third trimester: 23% of the women), antacids (max. in third trim.: 11%), as well as antiemetics and antinauseants (max. in first trim.: 8%) during pregnancy considerably increased. A decrease was seen for analgesics, antiinflammatory and antirheumatic drugs, muscle relaxants, ophtalmologicals and anti-acne preparations, for example. Potential teratogenic drugs were prescribed to 1.3% of the women. This analysis of a large nation-wide cohort of pregnant women showed that during pregnancy drugs were prescribed to most women, even when vitamins, minerals, iodide and iron were omitted. Magnesium and iron seemed to have been over-prescribed. On the other hand, the official recommendation for iodide substitution, to prevent thyroid diseases in mother and child, was insufficiently implemented. In our opinion, regular analysis of prescription data can identify potential harmful therapies and focal points where guidelines are needed and can check their implementation.Keywords
This publication has 17 references indexed in Scilit:
- Prescription of Drugs to Pregnant Women in France: the HIMAGE StudyTherapies, 2003
- Prescription drugs during pregnancy and lactation—a Finnish register-based studyEuropean Journal of Clinical Pharmacology, 2003
- Prescription of drugs during pregnancy in FranceThe Lancet, 2000
- Therapeutic drug use during pregnancy: a comparison in four European countries. OECM Working Group. Occupational Exposures and Congenital Anomalies.1999
- Therapeutic Drug Use During Pregnancy A Comparison in Four European CountriesJournal of Clinical Epidemiology, 1999
- Drug use in first pregnancy and lactation: a population-based survey among Danish womenEuropean Journal of Clinical Pharmacology, 1999
- Drugs in PregnancyNew England Journal of Medicine, 1998
- The PEGASUS project--a prospective cohort study for the investigation of drug use in pregnancy. PEGASUS Study Group.1997
- Investigating drug use in pregnancyInternational Journal of Clinical Pharmacy, 1991
- Drug use in pregnancy: an overview of epidemiological (drug utilization) studiesEuropean Journal of Clinical Pharmacology, 1990